HAMBURG, GERMANY / ACCESSWIRE / July 27, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that it is adjusting its guidance for the fiscal year 2023.
Due to the impact of the cyber-attack, the company now expects Group revenues in the range of € 750 – 790 m (previously € 820 – 840 m); unpartnered R&D is expected in a range of € 60 – 70 m (previously € 70 – 80 m); and the adjusted EBITDA is expected to reach € 60 – 80 m (previously € 115 – 130 m).
While one-off items are affecting the outlook for 2023, optimisation measures are set to unfold their positive impact over to course of 2024 and beyond. Action Plan 2025 stays unchanged, targeting revenues of more than € 1 bn and an adjusted EBITDA of more than € 300 m.
Contact:
Dr Werner Lanthaler
Chief Executive Officer
Evotec SE
Manfred Eigen Campus
Essener Bogen 7, 22419
Hamburg, Germany
Phone: +49.(0)40.560 81-0
werner.lanthaler@evotec.com
SOURCE: Evotec SE
View source version on accesswire.com:
https://www.accesswire.com/770736/Evotec-Provides-Update-on-Financial-Impact-of-Cyber-Attack
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural"…
CLEVELAND, May 28, 2025 /PRNewswire/ -- PartsSource, the leading technology and enterprise software platform for managing…
Nation's Leading Infrared and Red-Light Sauna Franchise to Debut in Cupertino, Morgan Hill and Los…
MARLBOROUGH, Mass., May 28, 2025 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today unveiled Phi…
CENTER VALLEY, Pa., May 28, 2025 /PRNewswire/ -- Aesculap, Inc. (Aesculap), an industry leader in sterile…
Industry-first device combines AI-powered EHR retrieval with wearable tech—putting verified medical history directly on your…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
